Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Trends in HPV-Associated Cancers in the US
MMWR; 2018 Aug 24; Van Dyne, Henley, et al
From 1999 to 2015, human papillomavirus (HPV)-associated cancer rates changed in the US, with oropharyngeal squamous cell carcinoma (SCC) now the most common HPV-associated cancer. The Centers for Disease Control and Prevention (CDC) analyzed data from cancer registries covering 97.8% of the US population. It found:
- There were 30,115 new cases of HPV-associated cancers in 1999 and 43,371 in 2015.
- During the study period, cervical carcinoma incidence cancer rates decreased by 1.6%.
- Oropharyngeal SCC incidence rates increased 2.7% per year during the same time period among men and 0.8% per year among women.
Although population-based screening is recommended for only 1 HPV-associated cancer (cervical) at this time, the authors offer that HPV vaccination can prevent infection with the HPV types most strongly associated with cancer.
Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus–associated cancers—United States, 1999–2015. MMWR Morb Mortal Wkly Rep 2018;67:918–924. doi:10.15585/mmwr.mm6733a2.
This Week's Must Reads
Must Reads in Infectious Diseases
Rapid Point of Care Test for Influenza, J Am Board Fam Med; 2019 Mar; Dale, et al
Invasive GBS Infections in Nonpregnant US Adults, JAMA Intern Med; ePub 2019 Feb 18; Francois Watkins, et al
Prescribed Opioids & Risk of CAP in Patients with HIV, JAMA Intern Med; 2019 Jan 7; Edelman, et al
Influenza Vaccination Safety During Hospitalization, Mayo Clin Proc; ePub 2019 Jan 8; Tartof, et al
Hospitalization Trends for Drug-Use Associated IE, Ann Intern Med; ePub 2018 Dec 4; Schranz, et al